Traumagel is a new hemostatic agent that has just been approved by the FDA.Cresilon
A new bleeding control tool called Traumagel, which earned the Food and Drug Administration’s medical device clearance on Wednesday, could change how first responders address severe bleeding.
Traumagel, which will launch later this year, is a 30-ml syringe of an algae- and fungi-based hemostatic gel that’s the color and texture of hummus. It can be applied directly into a wound, helping stanch bleeding within seconds. The FDA cleared its use for moderate to severe bleeding, Fast Company reports.
Joe Landolina, founder of Brooklyn-based Cresilon, which makes Traumagel, says that in addition to stopping bleeding quickly, the product’s “flowable” properties can improve the safety of treating something like a gunshot wound.
Cresilon says it is focused on Traumagel’s launch, and getting EMTs and physicians trained to use it.
